This document discusses antiparkinsonian drugs used to treat Parkinson's disease. It begins by introducing antiparkinsonian drugs and Parkinson's disease. It then classifies antiparkinsonian drugs into anticholinergic agents, dopaminergic agents, and monoamine oxidase type B inhibitors. One specific anticholinergic agent, trihexyphenidyl, is discussed in more detail, covering its trade name, classification, dosage, mechanism of action, indications, contraindications, side effects, and nursing responsibilities when administering the drug.